Filing Details
IMPACT BIOMEDICAL INC. (AMEX:IBO) filed a Form 8-K with the Securities and Exchange Commission on October 09, 2026, disclosing a material event.
8k filedAMEX:IBO
IMPACT BIOMEDICAL INC. (IBO) Reports Material Event to SEC
IMPACT BIOMEDICAL INC. (AMEX:IBO) filed a Form 8-K with the Securities and Exchange Commission on October 09, 2026, disclosing a material event.
At publication ·
What changed
IMPACT BIOMEDICAL INC. (AMEX:IBO) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Impact Biomedical Inc. filed a Form 8-K with the SEC on October 09, 2026, disclosing a material event requiring shareholder disclosure.
- The healthcare company's stock trades at $4.33 with a market capitalization of $6.1 million.
- Material events in 8-K filings include leadership changes, agreements, acquisitions, asset sales, or financial guidance modifications.
Market Context
IMPACT BIOMEDICAL INC.'s stock currently trades at $4.33 with a market capitalization of $6.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for IMPACT BIOMEDICAL INC.'s stock.
All SEC filings for IMPACT BIOMEDICAL INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View IBO Stock Page
Frequently Asked Questions
Where can I read IBO's SEC filings?
Browse all filings on our IBO SEC filings page.
What types of SEC filings does IMPACT BIOMEDICAL INC. file?
Public companies like IMPACT BIOMEDICAL INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.